375 related articles for article (PubMed ID: 15193681)
1. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: the Cardiovascular Health Study.
Drazner MH; Rame JE; Marino EK; Gottdiener JS; Kitzman DW; Gardin JM; Manolio TA; Dries DL; Siscovick DS
J Am Coll Cardiol; 2004 Jun; 43(12):2207-15. PubMed ID: 15193681
[TBL] [Abstract][Full Text] [Related]
2. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial.
Lonn E; Shaikholeslami R; Yi Q; Bosch J; Sullivan B; Tanser P; Magi A; Yusuf S
J Am Coll Cardiol; 2004 Jun; 43(12):2200-6. PubMed ID: 15193680
[TBL] [Abstract][Full Text] [Related]
3. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy.
Beladan CC; Popescu BA; Calin A; Rosca M; Matei F; Gurzun MM; Popara AV; Curea F; Ginghina C
Echocardiography; 2014 Mar; 31(3):325-34. PubMed ID: 24015855
[TBL] [Abstract][Full Text] [Related]
4. Progression from normal to reduced left ventricular ejection fraction in patients with concentric left ventricular hypertrophy after long-term follow-up.
Krishnamoorthy A; Brown T; Ayers CR; Gupta S; Rame JE; Patel PC; Markham DW; Drazner MH
Am J Cardiol; 2011 Oct; 108(7):997-1001. PubMed ID: 21798496
[TBL] [Abstract][Full Text] [Related]
5. Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study.
Nielsen ML; Pareek M; Gerke O; Leósdóttir M; Nilsson PM; Olsen MH
BMC Cardiovasc Disord; 2015 Dec; 15():168. PubMed ID: 26655187
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of reduced longitudinal left ventricular systolic function in hypertensive patients with normal ejection fraction.
Szelényi Z; Fazakas Á; Szénási G; Tegze N; Fekete B; Molvarec A; Hadusfalvy-Sudár S; Jánosi O; Kiss M; Karádi I; Vereckei A
J Hypertens; 2015 Sep; 33(9):1962-9; discussion 1969. PubMed ID: 26154942
[TBL] [Abstract][Full Text] [Related]
7. Long-term functional and clinical follow-up of patients with heart failure with recovered left ventricular ejection fraction after β-blocker therapy.
de Groote P; Fertin M; Duva Pentiah A; Goéminne C; Lamblin N; Bauters C
Circ Heart Fail; 2014 May; 7(3):434-9. PubMed ID: 24563449
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1.
Parrinello G; Licata A; Colomba D; Di Chiara T; Argano C; Bologna P; Corrao S; Avellone G; Scaglione R; Licata G
J Hum Hypertens; 2005 Jul; 19(7):543-50. PubMed ID: 15944724
[TBL] [Abstract][Full Text] [Related]
9. Relation of left ventricular mass and concentric remodeling to extent of coronary artery disease by computed tomography in patients without left ventricular hypertrophy: ROMICAT study.
Truong QA; Toepker M; Mahabadi AA; Bamberg F; Rogers IS; Blankstein R; Brady TJ; Nagurney JT; Hoffmann U
J Hypertens; 2009 Dec; 27(12):2472-82. PubMed ID: 19696685
[TBL] [Abstract][Full Text] [Related]
10. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study.
Bikkina M; Levy D; Evans JC; Larson MG; Benjamin EJ; Wolf PA; Castelli WP
JAMA; 1994 Jul; 272(1):33-6. PubMed ID: 8007076
[TBL] [Abstract][Full Text] [Related]
11. Portable echocardiography: an innovative tool in screening for cardiac abnormalities in the community.
Galasko GI; Lahiri A; Senior R
Eur J Echocardiogr; 2003 Jun; 4(2):119-27. PubMed ID: 12749873
[TBL] [Abstract][Full Text] [Related]
12. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
[TBL] [Abstract][Full Text] [Related]
13. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up.
Abergel E; Chatellier G; Hagege AA; Oblak A; Linhart A; Ducardonnet A; Menard J
J Am Coll Cardiol; 2004 Jul; 44(1):144-9. PubMed ID: 15234423
[TBL] [Abstract][Full Text] [Related]
14. Effect of renal artery revascularization on left ventricular hypertrophy, diastolic function, blood pressure, and the one-year outcome.
Rzeznik D; Przewlocki T; Kablak-Ziembicka A; Kozanecki A; Roslawiecka A; Lach J; Tracz W; Podolec P
J Vasc Surg; 2011 Mar; 53(3):692-7. PubMed ID: 21129903
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular ejection fraction is associated with prevalent and incident cardiovascular disease in patients with intermittent claudication - results from the CAVASIC Study.
Rantner B; Pohlhammer J; Stadler M; Peric S; Hammerer-Lercher A; Klein-Weigel P; Fraedrich G; Kronenberg F; Kollerits B
Atherosclerosis; 2015 Apr; 239(2):428-35. PubMed ID: 25682043
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
[TBL] [Abstract][Full Text] [Related]
17. A high triglyceride-glucose index is associated with left ventricular dysfunction and atherosclerosis.
Chiu TH; Tsai HJ; Chiou HC; Wu PY; Huang JC; Chen SC
Int J Med Sci; 2021; 18(4):1051-1057. PubMed ID: 33456363
[No Abstract] [Full Text] [Related]
18. Abnormal Global Longitudinal Strain Predicts Future Deterioration of Left Ventricular Function in Heart Failure Patients With a Recovered Left Ventricular Ejection Fraction.
Adamo L; Perry A; Novak E; Makan M; Lindman BR; Mann DL
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28559418
[TBL] [Abstract][Full Text] [Related]
19. [Left ventricular mass in children in relation to body surface area].
Szewczykowska M; Grygalewicz J; Szkiłładź-Skiba M
Med Wieku Rozwoj; 2009; 13(3):187-93. PubMed ID: 20081264
[TBL] [Abstract][Full Text] [Related]
20. Development and application of normal limits for left ventricular ejection fraction and volume measurements from 99mTc-sestamibi myocardial perfusion gates SPECT.
Rozanski A; Nichols K; Yao SS; Malholtra S; Cohen R; DePuey EG
J Nucl Med; 2000 Sep; 41(9):1445-50. PubMed ID: 10994721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
